PropertyValue
is ?:annotates of
?:authorAffiliation
  • [\'Pirogov Russian National Research Medical University, Moscow, Russia.\', \'Federal Center for Brain and Neurotechnology, Moscow, Russia.\']
?:citedBy
  • -1
?:creator
?:doi
  • 10.17116/jnevro2021121041101
?:doi
?:hasPublicationType
?:journal
  • Zhurnal nevrologii i psikhiatrii imeni S.S. Korsakova
is ?:pmid of
?:pmid
?:pmid
  • 34037362
?:publication_isRelatedTo_Disease
?:rankingScore_SJR
  • 0.135
?:rankingScore_hIndex
  • 12
?:title
  • [Amantadine in the treatment of Parkinson\'s disease. New opportunities in the context of COVID-19].
?:type
?:year
  • 2021

Metadata

Anon_0  
expand all